Search

Your search keyword '"Mentz, Robert J"' showing total 2,583 results

Search Constraints

Start Over You searched for: Author "Mentz, Robert J" Remove constraint Author: "Mentz, Robert J"
2,583 results on '"Mentz, Robert J"'

Search Results

151. Cardiovascular Burden of the V142I Transthyretin Variant.

154. Hypertensive diseases in pregnancy, cardiac structure and function later in life: Insights from the Genetic Epidemiology Network of Arteriopathy (GENOA) study

158. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

162. Heart Failure Clinical Trials in East and Southeast Asia Understanding the Importance and Defining the Next Steps

164. Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies

165. Differences in health care use and outcomes by the timing of in-hospital worsening heart failure

167. Intravenous iron therapy in heart failure with preserved ejection fraction: how far have we walked?

173. Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial

174. Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial

175. Relation of Dyspnea Severity on Admission for Acute Heart Failure With Outcomes and Costs

179. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

183. Charting a Roadmap for Heart Failure Biomarker Studies

184. Mineralocorticoid Receptor Antagonist Use in Hospitalized Patients With Heart Failure, Reduced Ejection Fraction, and Diabetes Mellitus (from the EVEREST Trial)

185. In‐Hospital Worsening Heart Failure and Associations With Mortality, Readmission, and Healthcare Utilization

186. Designing effective drug and device development programs for hospitalized heart failure: A proposal for pretrial registries

187. International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short‐term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial

188. Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions

189. Impact of baseline kidney dysfunction on oral diuretic efficacy following hospitalization for heart failure – insights from TRANSFORM‐HF.

190. Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trial.

191. Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure

193. Relationship of Race With Functional and Clinical Outcomes With the REHAB‐HF Multidomain Physical Rehabilitation Intervention for Older Patients With Acute Heart Failure

197. Association of Depression Symptoms and Biomarkers of Risk on Clinical Outcomes in HFrEF

198. Ferric Carboxymaltose in Heart Failure with Iron Deficiency

199. Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes

200. Relation of Serum Magnesium Levels and Postdischarge Outcomes in Patients Hospitalized for Heart Failure (from the EVEREST Trial)

Catalog

Books, media, physical & digital resources